Boltz
Open-source, AlphaFold3-class biomolecular structure and affinity prediction.
Full Boltz record →Head to head
Boltz vs Xaira Therapeutics
Boltz (MIT) and Xaira Therapeutics (Xaira Therapeutics) both sit in Science & Bio. Xaira Therapeutics shipped more tracked changes in the last 30 days (7 vs 5). Every value below comes from the latest crawl of the vendors' own pages.
| Attribute | Boltz MIT | Xaira Therapeutics Xaira Therapeutics |
|---|---|---|
| Segment | Science & Bio | Science & Bio |
| Version | Boltz-2 | Xaira Platform |
| Entry cost | Pricing is not published. API and Enterprise deployments available. | Pricing is not publicly disclosed (Enterprise/Drug Discovery Platform) |
| Pricing tiers | — | — |
| Model stack | Boltz-2 · BoltzGen · BoltzMol-1 · BoltzProt-1 | Proprietary · X-Atlas/Pisces · X-Automate · X-Cell · X-Design · X-Patient · X-Scientist |
| Context window | — | — |
| Public API | ||
| Routes models | ||
| Changes / 30d | 5 | 7 |
| Origin | United States | United States |
| Capabilities | Open weights, Affinity prediction, Complex structures, Local inference, Design small molecules, Design proteins, Predict structures, Fine-tuning | Generative protein design, Perturbation atlases, Wet-lab loop, predictive AI models, agentic AI models, virtual cells, drug discovery, AI models for drug discovery |
Xaira Therapeutics
Foundation-model-driven pipeline built on generative protein design and perturbation data.
Full Xaira Therapeutics record →